These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1320733)

  • 1. Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy.
    Lee SL; Ostadalova I; Kolar F; Dhalla NS
    Mol Cell Biochem; 1992 Feb; 109(2):173-9. PubMed ID: 1320733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrendipine binding in congestive heart failure due to myocardial infarction.
    Dixon IM; Lee SL; Dhalla NS
    Circ Res; 1990 Mar; 66(3):782-8. PubMed ID: 2155068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular calcium levels are unchanged in the diabetic heart.
    Yu JZ; Rodrigues B; McNeill JH
    Cardiovasc Res; 1997 Apr; 34(1):91-8. PubMed ID: 9217877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity to calcium associated with an increased sarcolemmal Ca2+-ATPase activity in diabetic rat heart.
    Borda E; Pascual J; Wald M; Sterin-Borda L
    Can J Cardiol; 1988 Mar; 4(2):97-101. PubMed ID: 2452676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcolemmal Ca2+ transport activities in cardiac hypertrophy caused by pressure overload.
    Nakanishi H; Makino N; Hata T; Matsui H; Yano K; Yanaga T
    Am J Physiol; 1989 Aug; 257(2 Pt 2):H349-56. PubMed ID: 2548404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
    Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
    Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.
    Norby FL; Wold LE; Duan J; Hintz KK; Ren J
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E658-66. PubMed ID: 12217882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK; Bolger GT
    Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy.
    Ganguly PK; Pierce GN; Dhalla KS; Dhalla NS
    Am J Physiol; 1983 Jun; 244(6):E528-35. PubMed ID: 6134470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypo- and hyperthyroidism on binding of [3H]-nitrendipine to myocardial and brain membranes.
    Kosinski C; Gross G; Hanft G
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):128S-130S. PubMed ID: 2176516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy.
    Ligeti L; Szenczi O; Prestia CM; Szabó C; Horváth K; Marcsek ZL; van Stiphout RG; van Riel NA; Op den Buijs J; Van der Vusse GJ; Ivanics T
    Int J Mol Med; 2006 Jun; 17(6):1035-43. PubMed ID: 16685413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone.
    Seppet EK; Kolar F; Dixon IM; Hata T; Dhalla NS
    Mol Cell Biochem; 1993 Dec; 129(2):145-59. PubMed ID: 8177237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy.
    Heyliger CE; Pierce GN; Singal PK; Beamish RE; Dhalla NS
    Basic Res Cardiol; 1982; 77(6):610-8. PubMed ID: 6297454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of verapamil on some subcellular defects in diabetic cardiomyopathy.
    Afzal N; Pierce GN; Elimban V; Beamish RE; Dhalla NS
    Am J Physiol; 1989 Apr; 256(4 Pt 1):E453-8. PubMed ID: 2523196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
    Bolger GT; Skolnick P
    Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca(2+)-channels and adrenoceptors in diabetic skeletal muscle.
    Lee SL; Dhalla NS
    Biochem Biophys Res Commun; 1992 Apr; 184(1):353-8. PubMed ID: 1314590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
    Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding.
    Yu Z; Tibbits GF; McNeill JH
    Am J Physiol; 1994 May; 266(5 Pt 2):H2082-9. PubMed ID: 8203606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.